Radiopeptides for Imaging and Therapy: A Radiant Future

被引：45

作者：

Chatalic, Kristell L. S. ^{[1
,2
,3
]}

Kwekkeboom, Dik J. ^{[1
]}

de Jong, Marion ^{[1
,2
]}

机构：

[1] Erasmus MC, Dept Nucl Med, NL-3000 CA Rotterdam, Netherlands

[2] Erasmus MC, Dept Radiol, NL-3000 CA Rotterdam, Netherlands

[3] Erasmus MC, Dept Urol, NL-3000 CA Rotterdam, Netherlands

来源：

JOURNAL OF NUCLEAR MEDICINE | 2015年 / 56卷 / 12期

关键词：

radiopeptides; imaging; radionuclide therapy; developments; perspectives; RECEPTOR RADIONUCLIDE THERAPY; PEPTIDES; ANTAGONISTS; (ALF)-F-18; DOSIMETRY;

D O I：

10.2967/jnumed.115.161158

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Radiopeptides are powerful tools for diagnostic imaging and radionuclide therapy of various diseases. Since the introduction of the first radiopeptide into the clinical setting to diagnose neuroendocrine tumors about 25 y ago, many advances have been made in the field. This short review highlights novel strategies to improve the application of radiopeptides for imaging and therapy.

引用

页码：1809 / 1812

页数：4

共 25 条

[1] Radiopeptide Imaging and Therapy in Europe [J].

Ambrosini, Valentina ;

Fani, Melpomeni ;

Fanti, Stefano ;

Forrer, Flavio ;

Maecke, Helmut R. .

JOURNAL OF NUCLEAR MEDICINE, 2011, 52 :42S-55S

[2] Localization of Hidden Insulinomas with 68Ga-DOTA-Exendin-4 PET/CT: A Pilot Study [J].

Antwi, Kwadwo ;

Fani, Melpomeni ;

Nicolas, Guillaume ;

Rottenburger, Christof ;

Heye, Tobias ;

Reubi, Jean Claude ;

Gloor, Beat ;

Christ, Emanuel ;

Wild, Damian .

JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (07) :1075-1078

[3] Dual-Labeling Strategies for Nuclear and Fluorescence Molecular Imaging: A Review and Analysis [J].

Azhdarinia, Ali ;

Ghosh, Pradip ;

Ghosh, Sukhen ;

Wilganowski, Nathaniel ;

Sevick-Muraca, Eva M. .

MOLECULAR IMAGING AND BIOLOGY, 2012, 14 (03) :261-276

[4] Peptide receptor radionuclide therapy using radiolabeled somatostatin analogs: Focus on future developments [J].

Bison S.M. ;

Konijnenberg M.W. ;

Melis M. ;

Pool S.E. ;

Bernsen M.R. ;

Teunissen J.J.M. ;

Kwekkeboom D.J. ;

de Jong M. .

Clinical and Translational Imaging, 2014, 2 (1) :55-66

[5] PRRT: Defining the Paradigm Shift to Achieve Standardization and Individualization [J].

Bodei, Lisa ;

Kidd, Mark ;

Baum, Richard P. ;

Modlin, Irvin M. .

JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (11) :1753-1756

[6] In Vivo Imaging of GLP-1R with a Targeted Bimodal PET/Fluorescence Imaging Agent [J].

Brand, Christian ;

Abdel-Atti, Dalya ;

Zhang, Yachao ;

Carlin, Sean ;

Clardy, Susan M. ;

Keliher, Edmund J. ;

Weber, Wolfgang A. ;

Lewis, Jason S. ;

Reiner, Thomas .

BIOCONJUGATE CHEMISTRY, 2014, 25 (07) :1323-1330

[7] Preclinical Comparison of Al18F- and 68Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonists for PET Imaging of Prostate Cancer [J].

Chatalic, Kristell L. S. ;

Franssen, Gerben M. ;

van Weerden, Wytske M. ;

McBride, William J. ;

Laverman, Peter ;

de Blois, Erik ;

Hajjaj, Bouchra ;

Brunel, Luc ;

Goldenberg, David M. ;

Fehrentz, Jean-Alain ;

Martinez, Jean ;

Boerman, Otto C. ;

de Jong, Marion .

JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (12) :2050-2056

[8]

Claringbold PG, 2015, NEUROENDOCRINOLOGY

[9] NeuroEndocrine Tumor Therapy with Lutetium-177-octreotate and Everolimus (NETTLE): A Phase I Study [J].

Claringbold, Phillip G. ;

Turner, J. Harvey .

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2015, 30 (06) :261-269

[10] Analysis of 177Lu-DOTA-Octreotate Therapy-Induced DNA Damage in Peripheral Blood Lymphocytes of Patients with Neuroendocrine Tumors [J].

Denoyer, Delphine ;

Lobachevsky, Pavel ;

Jackson, Price ;

Thompson, Mick ;

Martin, Olga A. ;

Hicks, Rodney J. .

JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (04) :505-511

← 1 2 3 →